... 加入收藏 获取最新 非何杰金氏淋巴瘤的治疗进展 沈志祥 张慧英 【摘要】： 正非何杰金氏淋巴瘤(Non-Hodgkin's Lymphomas,NHL)是血液系统恶性肿瘤,按工作分类法它可分为三大类:低度、中度和高度恶性NHL。
基于46个网页-相关网页
...组织如脾脏、胸腺及扁桃腺等所长出的恶性肿瘤，临床上常依肿瘤病理组织型态的不同将淋巴瘤分为何杰金氏淋巴瘤(Hodgkin's disease)与非何杰金氏淋巴 …
基于8个网页-相关网页
...疾病的起病方式、淋巴结外组织器官的累积率、病情进展情况和对治疗反应的不同，将淋巴瘤分为何杰金氏淋巴瘤（Hodgkin Lymphoma，HL）和非何杰金氏淋巴瘤（Non-Hodgkin Lymphoma，NHL）两 类。
基于4个网页-相关网页
非霍奇金氏淋巴瘤 non-Hodgkin lymphoma ; NHL
非何杰金氏淋巴瘤 NHL ; Non-Hodgkin's Lymphoma ; non-Hodgkin's b-cell lymphoma
何杰金氏淋巴瘤 Hodgkin's Lymphoma
霍奇金氏淋巴瘤 Non-Hodgkin's lymphoma ; Hodgkin's lymphoma ; Hodgkin'S disease ; NHL
非-何杰金氏淋巴瘤 Non- Hodgkin's Lymphoma
胞非何杰金氏淋巴瘤 diffuse large b cell lymphoma ; DLBC
杰金氏淋巴瘤 non-Hodgkins lymphoma ; NHL
研究非霍奇金氏淋巴瘤 non-Hodgkin's lymphoma
不同于霍奇金氏淋巴瘤 Hodgkin disease
与霍奇金氏淋巴瘤试验相似，试验主要终点是客观缓解率。
Similar to the HL trial, the trial's primary endpoint was objective response rate.
霍奇金氏淋巴瘤化疗完全缓解后的巩固放疗：真的需要吗？
Consolidation radiation after complete remission in Hodgkin's disease following chemotherapy: is there a need?
目的探讨IMOP方案治疗非霍奇金氏淋巴瘤的疗效和毒性。
Objective: To evaluate the efficacy and toxicity of IMOP regimen to treat non-Hodgkin′s lymphoma.
应用推荐